Lowering steroids for stable sarcoidosis
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial tests if people with stable sarcoidosis can safely lower their corticosteroid dose over time. It may help reduce side effects from long-term steroid use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sarcoidosis by biopsy or your doctor's team
- You have been taking prednisolone 5-10 mg each day for more than 6 months
- Your sarcoidosis has been stable for at least 6 months (no flare-ups or dose increases)
- You may be on an additional second-line medication
- You are over 18 years old
- You do not have sarcoidosis affecting your heart or nervous system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatment durations (6 months vs 12 months) of the steroid prednisolone for people with sarcoidosis affecting the lungs. The goal is to see if a shorter course works as well as a longer one, which might reduce side effects.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This trial tests whether sirolimus, a medicine that calms the immune system, can improve skin sarcoidosis on the face. It may help people whose skin symptoms are moderate to severe and haven't improved with other treatments.
This study looks at how the immune system works in people with sarcoidosis. It may help researchers find better ways to diagnose or treat the disease in the future.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
This trial tests a steroid medication called compound betamethasone for people with newly diagnosed pulmonary sarcoidosis (stage I or II). It may help reduce inflammation and improve symptoms compared to standard prednisone treatment.
Hear when a new Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.